Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Oncternal_Therapeutics
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:focusesOn |
hormone-related cancer therapies
selective androgen receptor modulators (SARMs) |
| gptkbp:foundedYear |
1997
|
| gptkbp:founder |
Marc S. Hanover
Mitchell S. Steiner |
| gptkbp:headquartersLocation |
gptkb:Memphis,_Tennessee,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
GTx, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
enobosarm
|
| gptkbp:tradedOn |
NASDAQ: GTXI
|
| gptkbp:bfsParent |
gptkb:Pitt_Hyde
gptkb:J._R._Hyde_III |
| gptkbp:bfsLayer |
8
|